Personal tools

CL:0000764

From FANTOM5_SSTAR

Revision as of 17:26, 26 June 2012 by Autoedit (talk | contribs)
Jump to: navigation, search
Name:erythroid lineage cell
Namespace:cell;;efo
Definition:"A immature or mature cell in the lineage leading to and including erythrocytes." [GOC:add, GOC:tfm]
Xrefs:
links:

FMA:62845

FMA:83516
Synonyms: "erythropoietic cell" EXACT []
Comments:Note that in FMA erythropoietic cells are types of nucleated erythrocytes and thus don't include erythrocytes.
Alt_id: CL:0002156


Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

Parents

is_a:CL:0000763(myeloid cell)



Children


is a:CL:0000038 (erythroid progenitor cell),CL:0000547 (proerythroblast),CL:0000558 (reticulocyte),CL:0000765 (erythroblast)
disjoint from:CL:0000556 (megakaryocyte)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)


FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

Human (Homo sapiens)

  • 11931-125I5 (CD34 cells differentiated to erythrocyte lineage, biol_ rep1)
  • 11932-125I6 (CD34 cells differentiated to erythrocyte lineage, biol_ rep2)
  • 13063-139I3 (J2E erythroblastic leukemia response to erythropoietin)
  • 13064-139I4 (J2E erythroblastic leukemia response to erythropoietin)
  • 13065-139I5 (J2E erythroblastic leukemia response to erythropoietin)
  • 13066-139I6 (J2E erythroblastic leukemia response to erythropoietin)
  • 13067-139I7 (J2E erythroblastic leukemia response to erythropoietin)
  • 13068-139I8 (J2E erythroblastic leukemia response to erythropoietin)
  • 13069-139I9 (J2E erythroblastic leukemia response to erythropoietin)
  • 13070-140A1 (J2E erythroblastic leukemia response to erythropoietin)

... further results Mouse (Mus musculus)

  • 11931-125I5 (CD34 cells differentiated to erythrocyte lineage, biol_ rep1)
  • 11932-125I6 (CD34 cells differentiated to erythrocyte lineage, biol_ rep2)
  • 13063-139I3 (J2E erythroblastic leukemia response to erythropoietin)
  • 13064-139I4 (J2E erythroblastic leukemia response to erythropoietin)
  • 13065-139I5 (J2E erythroblastic leukemia response to erythropoietin)
  • 13066-139I6 (J2E erythroblastic leukemia response to erythropoietin)
  • 13067-139I7 (J2E erythroblastic leukemia response to erythropoietin)
  • 13068-139I8 (J2E erythroblastic leukemia response to erythropoietin)
  • 13069-139I9 (J2E erythroblastic leukemia response to erythropoietin)
  • 13070-140A1 (J2E erythroblastic leukemia response to erythropoietin)

... further results


Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000764 (erythroid lineage cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

P-valueFFCPShort description
3.29e-195FFCP PHASE2:Hg19::chr11:115492263..115492265,+#_2692d9344d66030269b88cd88732d3fep@chr11:115492263..115492265, +
3.29e-195FFCP PHASE1:Hg19::chr4:82805715..82805717,+#_2692d9344d66030269b88cd88732d3fep@chr4:82805715..82805717, +
3.29e-195FFCP PHASE1:Hg19::chr6:155472342..155472346,-#_2692d9344d66030269b88cd88732d3fep@chr6:155472342..155472346, -
3.29e-195FFCP PHASE2:Hg19::chr1:5543682..5543685,+#_2692d9344d66030269b88cd88732d3fep@chr1:5543682..5543685, +
3.29e-195FFCP PHASE2:Hg19::chr12:75560876..75560881,+#_2692d9344d66030269b88cd88732d3fep@chr12:75560876..75560881, +
3.29e-195FFCP PHASE1:Hg19::chr1:5543682..5543685,+#_2692d9344d66030269b88cd88732d3fep@chr1:5543682..5543685, +
3.29e-195FFCP PHASE1:Hg19::chr7:23205190..23205198,+#_2692d9344d66030269b88cd88732d3fep10@KLHL7
3.29e-195FFCP PHASE2:Hg19::chr4:82805715..82805717,+#_2692d9344d66030269b88cd88732d3fep@chr4:82805715..82805717, +
3.29e-195FFCP PHASE1:Hg19::chr10:86596455..86596456,+#_2692d9344d66030269b88cd88732d3fep@chr10:86596455..86596456, +
3.29e-195FFCP PHASE2:Hg19::chr12:131245491..131245492,+#_2692d9344d66030269b88cd88732d3fep@chr12:131245491..131245492, +
3.29e-195FFCP PHASE2:Hg19::chr15:71406717..71406718,+#_2692d9344d66030269b88cd88732d3fep@chr15:71406717..71406718, +
3.29e-195FFCP PHASE2:Hg19::chr7:23205201..23205207,+#_2692d9344d66030269b88cd88732d3fep13@KLHL7
3.29e-195FFCP PHASE2:Hg19::chr14:96742091..96742094,-#_2692d9344d66030269b88cd88732d3fep@chr14:96742091..96742094, -
3.29e-195FFCP PHASE1:Hg19::chr6:10585661..10585670,+#_2692d9344d66030269b88cd88732d3fep26@GCNT2
3.29e-195FFCP PHASE2:Hg19::chr17:42343955..42343974,-#_2692d9344d66030269b88cd88732d3fep@chr17:42343955..42343974, -
3.29e-195FFCP PHASE1:Hg19::chr14:55799575..55799582,+#_2692d9344d66030269b88cd88732d3fep@chr14:55799575..55799582, +
3.29e-195FFCP PHASE1:Hg19::chr11:5247692..5247701,-#_2692d9344d66030269b88cd88732d3fep@chr11:5247692..5247701, -
3.29e-195FFCP PHASE2:Hg19::chr4:175593804..175593809,+#_2692d9344d66030269b88cd88732d3fep@chr4:175593804..175593809, +
3.29e-195FFCP PHASE1:Hg19::chr4:175593804..175593809,+#_2692d9344d66030269b88cd88732d3fep@chr4:175593804..175593809, +
3.29e-195FFCP PHASE2:Hg19::chr9:138852021..138852030,+#_2692d9344d66030269b88cd88732d3fep@chr9:138852021..138852030, +
3.29e-195FFCP PHASE2:Hg19::chr6:10585672..10585677,+#_2692d9344d66030269b88cd88732d3fep42@GCNT2
3.29e-195FFCP PHASE2:Hg19::chr1:25599018..25599028,+#_2692d9344d66030269b88cd88732d3fep3@RHD
3.29e-195FFCP PHASE1:Hg19::chr1:25599018..25599028,+#_2692d9344d66030269b88cd88732d3fep3@RHD
3.29e-195FFCP PHASE1:Hg19::chr11:5255612..5255613,-#_2692d9344d66030269b88cd88732d3fep10@HBD
3.29e-195FFCP PHASE1:Hg19::chr11:29581179..29581180,+#_2692d9344d66030269b88cd88732d3fep@chr11:29581179..29581180, +
3.29e-195FFCP PHASE2:Hg19::chr17:42392517..42392522,+#_2692d9344d66030269b88cd88732d3fep17@RUNDC3A
3.29e-195FFCP PHASE2:Hg19::chr2:71833597..71833600,+#_2692d9344d66030269b88cd88732d3fep@chr2:71833597..71833600, +
3.29e-195FFCP PHASE1:Hg19::chr2:71833597..71833600,+#_2692d9344d66030269b88cd88732d3fep@chr2:71833597..71833600, +
3.29e-195FFCP PHASE2:Hg19::chr4:190941380..190941381,+#_2692d9344d66030269b88cd88732d3fep@chr4:190941380..190941381, +
3.29e-195FFCP PHASE2:Hg19::chr3:49726561..49726577,+#_2692d9344d66030269b88cd88732d3fep3@RNF123
3.29e-195FFCP PHASE2:Hg19::chr19:19535964..19535966,+#_2692d9344d66030269b88cd88732d3fep@chr19:19535964..19535966, +
3.29e-195FFCP PHASE1:Hg19::chr4:190941380..190941381,+#_2692d9344d66030269b88cd88732d3fep@chr4:190941380..190941381, +
3.29e-195FFCP PHASE1:Hg19::chr3:49726561..49726577,+#_2692d9344d66030269b88cd88732d3fep3@RNF123
3.29e-195FFCP PHASE1:Hg19::chr19:19535964..19535966,+#_2692d9344d66030269b88cd88732d3fep@chr19:19535964..19535966, +
3.29e-195FFCP PHASE1:Hg19::chr13:23969126..23969130,+#_2692d9344d66030269b88cd88732d3fep@chr13:23969126..23969130, +
3.29e-195FFCP PHASE2:Hg19::chr9:123853258..123853276,-#_2692d9344d66030269b88cd88732d3fep@chr9:123853258..123853276, -
3.29e-195FFCP PHASE1:Hg19::chr7:23205201..23205207,+#_2692d9344d66030269b88cd88732d3fep13@KLHL7
3.29e-195FFCP PHASE2:Hg19::chr11:66676050..66676060,+#_2692d9344d66030269b88cd88732d3fep@chr11:66676050..66676060, +
3.29e-195FFCP PHASE2:Hg19::chr1:158580993..158580998,-#_2692d9344d66030269b88cd88732d3fep@chr1:158580993..158580998, -
3.29e-195FFCP PHASE1:Hg19::chr1:158580993..158580998,-#_2692d9344d66030269b88cd88732d3fep@chr1:158580993..158580998, -
3.29e-195FFCP PHASE1:Hg19::chr9:138852021..138852030,+#_2692d9344d66030269b88cd88732d3fep@chr9:138852021..138852030, +
3.29e-195FFCP PHASE1:Hg19::chr11:57416011..57416016,+#_2692d9344d66030269b88cd88732d3fep9@CLP1
3.29e-195FFCP PHASE1:Hg19::chr11:5248435..5248444,+#_2692d9344d66030269b88cd88732d3fep@chr11:5248435..5248444, +
3.29e-195FFCP PHASE2:Hg19::chr10:86596455..86596456,+#_2692d9344d66030269b88cd88732d3fep@chr10:86596455..86596456, +
3.29e-195FFCP PHASE1:Hg19::chr18:11740276..11740278,+#_2692d9344d66030269b88cd88732d3fep@chr18:11740276..11740278, +
3.29e-195FFCP PHASE1:Hg19::chr12:131245491..131245492,+#_2692d9344d66030269b88cd88732d3fep@chr12:131245491..131245492, +
3.29e-195FFCP PHASE1:Hg19::chr6:10585672..10585677,+#_2692d9344d66030269b88cd88732d3fep42@GCNT2
3.29e-195FFCP PHASE1:Hg19::chr11:5247730..5247736,-#_2692d9344d66030269b88cd88732d3fep@chr11:5247730..5247736, -
3.29e-195FFCP PHASE1:Hg19::chr13:106256314..106256318,+#_2692d9344d66030269b88cd88732d3fep@chr13:106256314..106256318, +
3.29e-195FFCP PHASE2:Hg19::chr4:160049078..160049079,+#_2692d9344d66030269b88cd88732d3fep@chr4:160049078..160049079, +
3.29e-195FFCP PHASE2:Hg19::chr11:5247692..5247701,-#_2692d9344d66030269b88cd88732d3fep@chr11:5247692..5247701, -
3.29e-195FFCP PHASE2:Hg19::chr6:10585684..10585689,+#_2692d9344d66030269b88cd88732d3fep37@GCNT2
3.29e-195FFCP PHASE2:Hg19::chr8:101412217..101412218,+#_2692d9344d66030269b88cd88732d3fep@chr8:101412217..101412218, +
3.29e-195FFCP PHASE1:Hg19::chr9:123853258..123853276,-#_2692d9344d66030269b88cd88732d3fep@chr9:123853258..123853276, -
3.29e-195FFCP PHASE1:Hg19::chr17:27188395..27188398,-#_2692d9344d66030269b88cd88732d3fep1@MIR451A
3.29e-195FFCP PHASE2:Hg19::chr9:45465498..45465501,+#_2692d9344d66030269b88cd88732d3fep@chr9:45465498..45465501, +
3.29e-195FFCP PHASE2:Hg19::chr4:26378984..26378987,+#_2692d9344d66030269b88cd88732d3fep@chr4:26378984..26378987, +
3.29e-195FFCP PHASE1:Hg19::chr16:15616042..15616045,+#_2692d9344d66030269b88cd88732d3fep@chr16:15616042..15616045, +
3.29e-195FFCP PHASE2:Hg19::chr3:49726589..49726592,+#_2692d9344d66030269b88cd88732d3fep7@RNF123
3.29e-195FFCP PHASE1:Hg19::chr4:26378984..26378987,+#_2692d9344d66030269b88cd88732d3fep@chr4:26378984..26378987, +
3.29e-195FFCP PHASE1:Hg19::chr3:49726589..49726592,+#_2692d9344d66030269b88cd88732d3fep7@RNF123
3.29e-195FFCP PHASE2:Hg19::chr11:5255612..5255613,-#_2692d9344d66030269b88cd88732d3fep10@HBD
3.29e-195FFCP PHASE2:Hg19::chr13:78682773..78682778,+#_2692d9344d66030269b88cd88732d3fep@chr13:78682773..78682778, +
3.29e-195FFCP PHASE2:Hg19::chr11:57415965..57415973,+#_2692d9344d66030269b88cd88732d3fep5@CLP1
3.29e-195FFCP PHASE2:Hg19::chr2:112191654..112191660,-#_2692d9344d66030269b88cd88732d3fep@chr2:112191654..112191660, -
3.29e-195FFCP PHASE2:Hg19::chr11:29581179..29581180,+#_2692d9344d66030269b88cd88732d3fep@chr11:29581179..29581180, +
3.29e-195FFCP PHASE1:Hg19::chr2:112191654..112191660,-#_2692d9344d66030269b88cd88732d3fep@chr2:112191654..112191660, -
3.29e-195FFCP PHASE2:Hg19::chr14:55799575..55799582,+#_2692d9344d66030269b88cd88732d3fep@chr14:55799575..55799582, +
3.29e-195FFCP PHASE1:Hg19::chr12:75560876..75560881,+#_2692d9344d66030269b88cd88732d3fep@chr12:75560876..75560881, +
3.29e-195FFCP PHASE2:Hg19::chr1:25598961..25598966,+#_2692d9344d66030269b88cd88732d3fep5@RHD
3.29e-195FFCP PHASE2:Hg19::chr16:227522..227524,+#_2692d9344d66030269b88cd88732d3fep@chr16:227522..227524, +
3.29e-195FFCP PHASE1:Hg19::chr1:25598961..25598966,+#_2692d9344d66030269b88cd88732d3fep5@RHD
3.29e-195FFCP PHASE2:Hg19::chr1:207823590..207823599,+#_2692d9344d66030269b88cd88732d3fep@chr1:207823590..207823599, +
3.29e-195FFCP PHASE1:Hg19::chr4:160049078..160049079,+#_2692d9344d66030269b88cd88732d3fep@chr4:160049078..160049079, +
3.29e-195FFCP PHASE1:Hg19::chr6:10585684..10585689,+#_2692d9344d66030269b88cd88732d3fep37@GCNT2
3.29e-195FFCP PHASE1:Hg19::chr15:71406717..71406718,+#_2692d9344d66030269b88cd88732d3fep@chr15:71406717..71406718, +
3.29e-195FFCP PHASE1:Hg19::chr8:101412217..101412218,+#_2692d9344d66030269b88cd88732d3fep@chr8:101412217..101412218, +
3.29e-195FFCP PHASE1:Hg19::chr17:42366115..42366125,+#_2692d9344d66030269b88cd88732d3fep@chr17:42366115..42366125, +
3.29e-195FFCP PHASE1:Hg19::chr14:96742091..96742094,-#_2692d9344d66030269b88cd88732d3fep@chr14:96742091..96742094, -
3.29e-195FFCP PHASE2:Hg19::chr11:5248435..5248444,+#_2692d9344d66030269b88cd88732d3fep@chr11:5248435..5248444, +
3.29e-195FFCP PHASE2:Hg19::chr6:50700492..50700495,+#_2692d9344d66030269b88cd88732d3fep@chr6:50700492..50700495, +
3.29e-195FFCP PHASE1:Hg19::chr6:50700492..50700495,+#_2692d9344d66030269b88cd88732d3fep@chr6:50700492..50700495, +
3.29e-195FFCP PHASE1:Hg19::chr9:45465498..45465501,+#_2692d9344d66030269b88cd88732d3fep@chr9:45465498..45465501, +
3.29e-195FFCP PHASE1:Hg19::chr10:94679592..94679594,-#_2692d9344d66030269b88cd88732d3fep@chr10:94679592..94679594, -
3.29e-195FFCP PHASE2:Hg19::chr11:5247730..5247736,-#_2692d9344d66030269b88cd88732d3fep@chr11:5247730..5247736, -
3.29e-195FFCP PHASE2:Hg19::chrX:107332036..107332041,+#_2692d9344d66030269b88cd88732d3fep@chrX:107332036..107332041, +
3.29e-195FFCP PHASE1:Hg19::chrX:107332036..107332041,+#_2692d9344d66030269b88cd88732d3fep@chrX:107332036..107332041, +
3.29e-195FFCP PHASE2:Hg19::chr16:67228546..67228549,+#_2692d9344d66030269b88cd88732d3fep@chr16:67228546..67228549, +
3.29e-195FFCP PHASE2:Hg19::chr2:62801311..62801318,+#_2692d9344d66030269b88cd88732d3fep@chr2:62801311..62801318, +
3.29e-195FFCP PHASE2:Hg19::chr3:49726593..49726603,+#_2692d9344d66030269b88cd88732d3fep4@RNF123
3.29e-195FFCP PHASE1:Hg19::chr3:49726593..49726603,+#_2692d9344d66030269b88cd88732d3fep4@RNF123
3.29e-195FFCP PHASE1:Hg19::chr17:42343955..42343974,-#_2692d9344d66030269b88cd88732d3fep@chr17:42343955..42343974, -
3.29e-195FFCP PHASE2:Hg19::chr21:27203678..27203684,+#_2692d9344d66030269b88cd88732d3fep@chr21:27203678..27203684, +
3.29e-195FFCP PHASE1:Hg19::chr1:207823590..207823599,+#_2692d9344d66030269b88cd88732d3fep@chr1:207823590..207823599, +
3.29e-195FFCP PHASE1:Hg19::chr11:66676050..66676060,+#_2692d9344d66030269b88cd88732d3fep@chr11:66676050..66676060, +
3.29e-195FFCP PHASE2:Hg19::chr20:24432163..24432165,+#_2692d9344d66030269b88cd88732d3fep@chr20:24432163..24432165, +
3.29e-195FFCP PHASE2:Hg19::chr1:25598971..25598977,+#_2692d9344d66030269b88cd88732d3fep4@RHD
3.29e-195FFCP PHASE1:Hg19::chr1:25598971..25598977,+#_2692d9344d66030269b88cd88732d3fep4@RHD
3.29e-195FFCP PHASE2:Hg19::chr1:2250692..2250695,+#_2692d9344d66030269b88cd88732d3fep@chr1:2250692..2250695, +
3.29e-195FFCP PHASE1:Hg19::chr1:2250692..2250695,+#_2692d9344d66030269b88cd88732d3fep@chr1:2250692..2250695, +

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=CL:0000764&oldid=1836661"